OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Increased serum asprosin is correlated with diabetic nephropathy
Rui Wang, Peng Lin, Huibo Sun, et al.
Diabetology & Metabolic Syndrome (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Asprosin in health and disease, a new glucose sensor with central and peripheral metabolic effects
Mariam Farrag, Djedjiga Ait Eldjoudi, María González‐Rodriguez, et al.
Frontiers in Endocrinology (2023) Vol. 13
Open Access | Times Cited: 38

Sensitive asprosin detection in clinical samples reveals serum/saliva correlation and indicates cartilage as source for serum asprosin
Yousef Ashraf Tawfik Morcos, Steffen Lütke, Antje Tenbieg, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 29

Asprosin in the Paraventricular Nucleus Induces Sympathetic Activation and Pressor Responses via cAMP-Dependent ROS Production
Xiaoli Wang, Jing-Xiao Wang, Jun-Liu Chen, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12595-12595
Open Access | Times Cited: 29

The Effects of Asprosin on Exercise-Intervention in Metabolic Diseases
Lifei Liu, Yuhao Liu, Mei Huang, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 20

Adipocyte-secreted ANGPTL2 promotes hyperuricemia through inhibiting AKT/ABCG2 signaling
Longyan Yang, Ruili Yin, Zhaochen Shan, et al.
Free Radical Biology and Medicine (2025)
Open Access

Asprosin, a C-Terminal Cleavage Product of Fibrillin 1 Encoded by the <b><i>FBN1</i></b> Gene, in Health and Disease
Mehmet Akif Ovalı, İbrahim Bozgeyik
Molecular Syndromology (2022) Vol. 13, Iss. 3, pp. 175-183
Open Access | Times Cited: 16

Correlation of asprosin and Nrg-4 with type 2 diabetes Mellitus Complicated with Coronary Heart Disease and the Diagnostic Value
Min Zhong, Xue Tian, Qitian Sun, et al.
BMC Endocrine Disorders (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 9

Circulating asprosin levels in type 2 diabetes mellitus: A systematic review and meta-analysis
Roshan Kumar Mahat, Ashwini Manish Jantikar, Vedika Rathore, et al.
Clinical Epidemiology and Global Health (2024) Vol. 25, pp. 101502-101502
Open Access | Times Cited: 3

Asprosin: its function as a novel endocrine factor in metabolic-related diseases
Yang Zhang, Ping Yang, Xinliang Zhang, et al.
Journal of Endocrinological Investigation (2024) Vol. 47, Iss. 8, pp. 1839-1850
Closed Access | Times Cited: 3

Asprosin is positively associated with metabolic syndrome in hemodialysis patients: a cross-sectional study
Jian Zhou, Weijie Yuan, Yunshan Guo, et al.
Renal Failure (2023) Vol. 45, Iss. 1
Open Access | Times Cited: 7

Fibrillin-1 and asprosin, novel players in metabolic syndrome
Kim Summers, Stephen J. Bush, Margaret R. Davis, et al.
Molecular Genetics and Metabolism (2022) Vol. 138, Iss. 1, pp. 106979-106979
Closed Access | Times Cited: 11

Can the new adipokine asprosin be a metabolic troublemaker for cardiovascular diseases? A state-of-the-art review
Zhengbin Zhang, Liwen Zhu, Ziqian Wang, et al.
Progress in Lipid Research (2023) Vol. 91, pp. 101240-101240
Closed Access | Times Cited: 6

Association Between Serum Asprosin and Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus in the Community: A Cross-Sectional Study
Linxin Xu, Junfang Cui, Mina Li, et al.
Diabetes Metabolic Syndrome and Obesity (2022) Vol. Volume 15, pp. 1877-1884
Open Access | Times Cited: 9

Asprosin levels in patients with type 2 diabetes mellitus, metabolic syndrome and obesity: A systematic review and meta-analysis
Juan R. Ulloque‐Badaracco, Ali Al‐kassab‐Córdova, Enrique A. Hernández-Bustamante, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2024) Vol. 18, Iss. 7, pp. 103095-103095
Closed Access | Times Cited: 1

The relationship between 25-hydroxy vitamin D and serum asprosin in patients with type 2 diabetes in the community
Junfang Cui, Zhengqian Wang, Jianhong Yin, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 1

Relation of the intense physical exercise and asprosin concentrations in type 2 diabetic rats
Muzaffer Katar, Fikret Gevrek
Tissue and Cell (2024) Vol. 90, pp. 102501-102501
Closed Access | Times Cited: 1

Concentration of Asprosin Associated with Poor Control of Type 2 Diabetes Mellitus in Diyala Province
Alaa Abed Mahmoud, Walaa Ismael Jassim, Ahmed Abdul Hussein Mohsin, et al.
Journal of Techniques (2023) Vol. 5, Iss. 2, pp. 123-128
Open Access | Times Cited: 2

Metformin modulates mitochondrial autophagy in renal tubular epithelial injury induced by high glucose via the Keap1/Nrf2 pathway
Da Sun, Huimin Li, Yinke Du, et al.
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 9, pp. 2483-2496
Closed Access | Times Cited: 2

Effects of N-acetylcysteine on spexin immunoreactivity in kidney tissues of rats treated with adriamycin.
Tuba Yalçın, Tuncay Kuloğlu, Nalan Kaya Tektemur, et al.
PubMed (2024) Vol. 27, Iss. 2, pp. 233-240
Closed Access

The correlation between serum asprosin and left ventricular diastolic dysfunction in elderly patients with type 2 diabetes mellitus in the community
Liang Dong, Guoliang Shi, Mingang Xu, et al.
Journal of Diabetes Investigation (2024) Vol. 15, Iss. 5, pp. 608-613
Open Access

Increased serum asprosin is correlated with diabetes mellitus-induced erectile dysfunction
Chunhui Li, Xue Zhao, Yi Xu, et al.
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access

Research Progress of Proinflammatory Adipokines and Type 2 Diabetic Nephropathy
丽萍 高
Journal of Clinical Personalized Medicine (2024) Vol. 03, Iss. 02, pp. 308-314
Open Access

Asprosin, a prospective biomarker for rhabdomyolysis-induced acute kidney damage in rats: involvement of PKA/TGF-β1/SMAD-3 signaling pathway
Sama Khalil, Samaa Abd El-Fatah, Maha Fathy, et al.
Zagazig University Medical Journal (2023)
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top